Skip to content

Prime Medicine PRME Accumulated Depreciation

Accumulated Depreciation at other companies

Precigen logo
PrecigenPGEN
$24.6M+6.1%

Other financials

Income statement

See full
Revenue$838.0K-61.6%
Operating income-$50.7M+3.3%
Net income-$49.1M+5.3%
EPS (diluted)-$0.28+30.0%

Balance sheet

See full
Cash & equivalents$77.8M-26.6%
Total debt$114.5M-5.5%
Total equity$76.7M-28.3%
Total assets$294.7M-10.2%

Cash flow

See full
Operating cash flow-$42.7M+12.6%
CapEx$214.0K-91.2%
Free cash flow-$42.9M+16.3%

Valuation

See full
Market cap$574.36M+111%
Enterprise value$611.08M+113%
P/S124×+6.3×

Profitability

See full
Operating margin-4,498.1%-1,134pp
Net margin-4,342.4%-1,099pp
FCF margin-3,607.4%

Returns & leverage

See full
Return on equity-216.1%+1,519pp
Debt / equity1.5×+0.4×
Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's accumulated depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prime Medicine's accumulated depreciation?
Prime Medicine (PRME) reported accumulated depreciation of $22.29M in Q1 2026.
How has Prime Medicine's accumulated depreciation changed year-over-year?
Prime Medicine's accumulated depreciation increased by 45.7% year-over-year, from $15.3M to $22.29M.
What is the long-term trend for Prime Medicine's accumulated depreciation?
Over 4 years (2021 to 2025), Prime Medicine's accumulated depreciation has grown at a 140.5% compound annual growth rate (CAGR), from $611K to $20.43M.
What does accumulated depreciation mean?
Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.